Bibliography
- Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001;19(3):180-92
- Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5(1):32-45
- Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002;296(5573):1646-7
- Kawamura K, Chu CR, Sobajima S, et al. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol 2005;33(8):865-72
- Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107(4):1484-90
- Yamaza T, Miura Y, Bi Y, et al. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One 2008;3(7):e2615
- Bueno EM, Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009;5(12):685-97
- Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 2011;17(12):1594-601
- Lourenco EV, La Cava A. Natural regulatory T cells in autoimmunity. Autoimmunity 2011;44(1):33-42
- Zhou G, Ding ZC, Fu J, et al. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specificCD4+ T cell response. J Immunol 2011;186(4):2148-55
- Li C, Bi W, Gong Y, et al. Transforming growth factor-beta1 inhibits tissue engineering cartilage absorption via inducing the generation of regulatory T cells. J Tissue Eng Regen Med 2013. [Epub ahead of print]
- Davis AM, Hagan KA, Matthews LA, et al. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol 2008;180(10):6923-32
- Al-Attiyah R, El-Shazly A, Mustafa AS. Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients. Scand J Immunol 2012;75(6):623-32
- Zhang Z, Kaptanoglu L, Tang Y, et al. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 2004;126(3):809-18
- Su H, Ye DQ, Wang BL, et al. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murinelupus-like syndrome of chronic graft versus-host disease. Br J Dermatol 2008;158(6):1197-209
- Nakamura K, Kitani A, Strober W. Cell contact-dependent immune suppression by CD4(+) CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194(5):629-44
- Zhou X, Kong N, Zou H, et al. Therapeutic potential of TGF-beta1-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity 2011;44(1):43-50
- He H, Cheng-long H, Chao J, et al. Effect of transforming growth factor beta 1 on differentiation of bone marrow mesenchymal stem cells into nucleus pulposus-like cells. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu 2011;15(36):6722-6
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299(5609):1057-61